This review systematically examines the tripartite relationship between vitamin D status, thyroid dysfunction, and autoimmune activity in HT, with particular focus on three key aspects: VDR polymorphisms in HT susceptibility; Vitamin D-mediated immunomodulatory mechanisms; Clinical implications of vitamin D repletion therapy. This evidence concerns the gene VDR and hematocrit.